58 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Rank Status Study
21 Unknown  The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure
Conditions: Hyperparathyroidism;   Hypertension
Intervention: Procedure: parathyroidectomy
22 Recruiting EC17 for Intraoperative Imaging for Parathyroidectomy
Condition: Primary Hyperparathyroidism
Intervention: Drug: EC17
23 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
24 Recruiting Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
Conditions: Kidney Failure;   Secondary Hyperparathyroidism;   Hyperphosphatemia;   Hypercalcemia
Interventions: Drug: Calcitriol;   Drug: Paricalcitol
25 Not yet recruiting Renal Osteodystrophy: An Individual Management Approach
Condition: Kidney Failure, Chronic
Interventions: Drug: Alendronate;   Drug: Teriparatide;   Drug: Cinacalcet
26 Recruiting The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
Condition: Hyperparathyroidism
Interventions: Drug: captopril;   Drug: Lisinopril
27 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
28 Not yet recruiting Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis
Condition: Secondary Hyperparathyroidism, Chronic Kidney Disease
Intervention: Drug: Cinacalcet
29 Recruiting Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
Condition: Hyperparathyroidism
Intervention: Radiation: F18-choline  PET examination
30 Unknown  Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
Conditions: Primary Hyperparathyroidism;   Bone Metabolism
Intervention: Drug: Calcium and vitamin D
31 Recruiting Studies of Inherited Diseases of Metabolism
Conditions: Hypercalcemia;   Hyperparathyroidism;   Multiple Endocrine Neoplasia
Intervention:
32 Unknown  Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Conditions: Chronic Kidney Disease;   Renal Osteodystrophy;   Left Ventricular Hypertrophy
Intervention:
33 Unknown  Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Hypovitaminosis D;   Hypomagnesemia;   Hyperparathyroidism
Intervention:
34 Recruiting Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Conditions: Breast Cancer;   Prostate Cancer;   Bone Neoplasms;   Hypocalcemia;   Hyperparathyroidism, Secondary
Intervention: Drug: CTAP101 Capsules
35 Not yet recruiting Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: standard care;   Drug: Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D
36 Not yet recruiting Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Combination Cinacalcet with Vitamin D analogue
37 Recruiting A Prospective Open-Label, Non-randomised, Single-arm, Pilot Clinical Study Evaluating the Effect of PTH Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
Conditions: Moderate to Severe Secondary Hyperparathyroidism;   Stage 5 Chronic Kidney Diseases
Intervention: Drug: Paricalcitol
38 Recruiting The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
Condition: Primary Hyperparathyroidism
Intervention:
39 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects
Intervention:
40 Recruiting 11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues
Conditions: Primary Hyperparathyroidism;   Tertiary Hyperparathyroidism
Interventions: Radiation: 11C-Methionine PET/CT scanning;   Radiation: 18F-FDG PET/CT scanning;   Radiation: SPECT-CT scanning

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Indicates status has not been verified in more than two years